4-aminopyridine has been researched along with ly 300164 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carcache, D; Kalkman, HO; Koller, M; Mattes, H | 1 |
| Kardos, J; Kovács, I; Skuban, N; Szárics, E | 1 |
2 other study(ies) available for 4-aminopyridine and ly 300164
| Article | Year |
|---|---|
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) antagonists: from bench to bedside.
Topics: Analgesics; Animals; Anticonvulsants; Antipsychotic Agents; Clinical Trials as Topic; Drug Evaluation, Preclinical; Humans; Neuroprotective Agents; Protein Subunits; Receptors, AMPA | 2010 |
Deramciclane inhibits N-methyl-D-aspartate receptor function.
Topics: 4-Aminopyridine; Animals; Anti-Anxiety Agents; Aspartic Acid; Benzodiazepines; Calcium; Camphanes; Cerebral Cortex; Dizocilpine Maleate; Drug Synergism; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Magnesium; Male; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate | 2000 |